| Literature DB >> 30574515 |
Paul M Ryan1, Robert C Turner1, Claude D Anderson1, Adam T Groth2.
Abstract
BACKGROUND: The treatment of osteochondral lesions of the talus (OLTs) with a juvenile cartilage allograft is a relatively new procedure. Although other treatment options exist for large OLTs, the potential advantage of a particulated juvenile allograft is the ability to perform the procedure arthroscopically or through a minimal approach. No previous studies have looked at the results of an arthroscopic approach, nor have any compared an arthroscopic technique with an open approach.Entities:
Keywords: ankle; arthroscopic surgery; osteochondral defect; particulated allograft
Year: 2018 PMID: 30574515 PMCID: PMC6295701 DOI: 10.1177/2325967118812710
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.Arthroscopic images of particulated allograft insertion.
Demographics of Patients
| Open (n = 14) | Arthroscopic (n = 20) |
| |
|---|---|---|---|
| Age, y | 33 (19-45) | 32 (20-52) | .94, .85, .76 |
| Lesion width, mm | 8.7 (5-16) | 8.6 (4-15) | .72, .93, >.99 |
| Lesion depth, mm | 4.1 (1-10) | 3.3 (0-10) | .81, .45, .48 |
| Lesion length, mm | 12.4 (7-15) | 12.4 (6-20) | .06, .95, .89 |
| Operative time, min | 141 (83-253) | 159 (64-304) | .19, .34, .32 |
Data are presented as mean (range). P values are shown for folded F test, pooled t test, and Wilcoxon test, respectively.
Outcome Scores
| Open | Arthroscopic |
| |
|---|---|---|---|
| VAS | |||
| At 2 y | 36.0 ± 23.8 (2.0 to 63.0) | 19.3 ± 28.7 (0.0 to 62.0) | |
| Change from baseline | 3.0 ± 11.9 (–18.0 to 10.0) [n = 5] | –25.0 ± 28.5 (–56.0 to 0.0) [n = 4] | .13, .09, .12 |
| AOFAS | |||
| At 2 y | 85.0 ± 0.0 (85.0 to 85.0) | 86.0 ± 19.1 (64.0 to 97.0) | |
| Change from baseline | 7.0 ± 9.9 (0.0 to 14.0) [n = 2] | 34.0 ± 15.6 (23.0 to 45.0) [n = 3] | .72, .17, .33 |
| FAAM-ADL | |||
| At 2 y | 77.4 ± 15.8 (43.8 to 98.8) | 79.9 ± 16.7 (54.8 to 100.0) | |
| Change from baseline | 12.2 ± 21.4 (–25.0 to 49.3) [n = 11] | 15.6 ± 25.1 (–23.6 to 56.0) [n = 11] | .66, .76, .61 |
| FAAM-sports | |||
| At 2 y | 54.2 ± 28.0 (19.4 to 94.4) | 60.5 ± 26.2 (19.4 to 100.0) | |
| Change from baseline | 27.4 ± 33.4 (–19.0 to 78.0) [n = 10] | 34.0 ± 41.3 (–41.0 to 97.0) [n = 9] | .59, .73, .72 |
| SF-12 physical health summary | |||
| At 2 y | 44.6 ± 7.1 (33.2 to 55.1) | 42.8 ± 11.0 (24.3 to 56.7) | |
| Change from baseline | 6.5 ± 11.1 (–13.5 to 23.4) [n = 11] | 7.6 ± 14.5 (–17.0 to 29.0) [n = 11] | .47, .85, .78 |
| SF-12 mental health summary | |||
| At 2 y | 54.3 ± 12.0 (33.5 to 68.7) | 59.1 ± 4.2 (50.0 to 63.5) | |
| Change from baseline | 1.0 ± 18.9 (–33.2 to 23.7) [n = 11] | 1.8 ± 7.0 (–9.0 to 12.9) [n = 11] | .01, .91, >.99 |
Data are presented as mean ± SD (range). P values are shown for folded F test, pooled t test, and Wilcoxon test, respectively. ADL, activities of daily living; AOFAS, American Orthopaedic Foot and Ankle Society; FAAM, Foot and Ankle Ability Measure; SF-12, 12-Item Short Form Health Survey; VAS, visual analog scale.
Change in Visual Analog Scale Scores
| Open | Arthroscopic | ||||
|---|---|---|---|---|---|
| Mean ± SD (Minimum, Median, Maximum) | 95% CI | Mean ± SD (Minimum, Median, Maximum) | 95% CI |
| |
| 6 mo | –15.7 ± 22.5 (–45.0, –17.0, 27.0) [n = 7] | –36.6 to 5.1 | –27.3 ± 25.3 (–67.0, –18.0, 14.0) [n = 9] | –46.8 to –7.8 | .7964, .3566, .5010 |
| 12 mo | –13.6 ± 29.6 (–52.0, –9.0, 26.0) [n = 5] | –50.3 to 23.1 | –25.0 ± 28.1 (–64.0, –17.0, 15.0) [n = 7] | –51.0 to 1.0 | .8673, .5133, .4340 |
| 18 mo | 0.0 ± 21.9 (–19.0, –5.0, 24.0) [n = 3] | –54.5 to 54.5 | –27.0 ± 19.8 (–41.0, –27.0, –13.0) [n = 2] | –204.9 to 150.9 | >.9999, .2581, .4353 |
| 2 y | 3.0 ± 11.9 (–18.0, 8.0, 10.0) [n = 5] | –11.8 to 17.8 | –25.0 ± 28.5 (–56.0, –19.0, 0.0) [n = 3] | –95.7 to 45.7 | .1345, .0916, .1150 |
values are shown for folded F test, pooled t test, and Wilcoxon test, respectively. Differences from baseline are depicted with a negative number when the patient’s pain level improved.
SF-12 Mental Health Summary Scores
| Open | Arthroscopic | ||||
|---|---|---|---|---|---|
| Mean ± SD (Minimum, Median, Maximum) | 95% CI | Mean ± SD (Minimum, Median, Maximum) | 95% CI |
| |
| 6 mo | 1.0 ± 6.8 (–9.5, 2.3, 9.8) [n = 7] | –5.3 to 7.3 | –2.0 ± 8.2 (–15.9, –2.8, 12.6) [n = 11] | –7.5 to 3.5 | .6708, .4409, .4786 |
| 12 mo | –3.3 ± 14.7 (–20.9, –7.2, 13.2) [n = 7] | –16.8 to 10.3 | –1.4 ± 11.1 (–19.2, –2.4, 16.2) [n = 11] | –8.8 to 6.1 | .4159, .7585, .7215 |
| 18 mo | –11.2 ± 10.8 (–20.5, –13.7, 0.6) [n = 3] | –38.0 to 15.6 | –1.0 ± 9.4 (–13.0, –2.1, 17.9) [n = 10] | –7.8 to 5.7 | .6356, .1396, .2289 |
| 2 y | 1.0 ± 18.9 (–33.2, 10.3, 23.7) [n = 9] | –13.5 to 15.5 | 1.8 ± 7.0 (–9.0, 0.6, 12.9) [n = 10] | –3.2 to 6.8 | .0074, .9080, |
values are shown for folded F test, pooled t test, and Wilcoxon test, respectively. SF-12, 12-Item Short Form Health Survey.
Satterthwaite t test.
Concomitant Procedures
| Open (n = 14) | Arthroscopic (n = 20) | |
|---|---|---|
| Modified Broström | 0/13 | 6/19 |
| Synovectomy | 12/13 | 9/19 |
| Osteophyte removal | 2/13 | 2/19 |
| Impingement removal | 2/13 | 2/13 |
| Loose body removal | 1/13 | 4/19 |
Data are presented as No.